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Abstract
Recently, surgical instruments and imaging technology in ophthalmology have 
shown a great improvement. However, advances in the field of the operating micro-
scope technology still remained unchanged with the various limitations for the 
surgeons. Invention of optical coherence tomography (OCT) led to a revolution in 
the diagnosis and monitoring of numerous anterior and posterior segment patholo-
gies. Recently, OCT has been introduced into the operating room with an impact on 
the surgeons. In this chapter, we review the evolution of OCT for intraoperative use 
with its feasibility, surgical impacts, and limitations.
Keywords: intraoperative optical coherence tomography, microscope-integrated, 
anterior segment iOCT, posterior segment iOCT
1. Introduction
Optical coherence tomography (OCT) is a rapid, noninvasive, noncontact, and 
cross-sectional imaging method that produces images of ocular tissues. OCT uses 
reflected light to obtain the images from the different layers on the ocular tissues 
that produce different backscattered lights [1]. After using of spectral-domain OCT 
(SD-OCT) instead of time-domain OCT (TD-OCT), the images produced by OCT 
have become with higher resolution; thus, OCT has begun to provide more detailed 
information on ophthalmologic diagnoses [2]. Recent developments in ocular 
imaging technology have made the OCT a vital diagnostic tool in patient care. More 
recently, the availability of OCT during surgery has begun to be discussed. The 
introduction of OCT into the operating room (OR) called as intraoperative OCT 
(iOCT) has provided new insights into the surgical management during ophthalmic 
surgeries.
2. Intraoperative OCT
A number of researchers have examined the potential role of iOCT in various 
conditions and procedures, such as macular hole (MH), epiretinal membrane 
(ERM), retinal detachment surgery, and lamellar keratoplasty [3–6]. However, 
conventional clinical OCT devices are large and not portable; therefore, it would 
be difficult and impractical to transfer the conventional OCTs into OR. In addi-
tion, the supine position of the patient during a surgery and changes to surgical 
flow are other potential obstacles for image acquisition with good quality. All these 
hurdles forced researchers to produce a portable OCT device. Initial attempts with 
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intraoperative OCT indicated successful results in imaging of excised tumors, 
postmortem specimens, structural changes after laser surgery, and in vitro human 
arteries and nerves [7–10]. Early investigations with iOCT were based on time-
domain technology. Nevertheless, these investigations resulted in suboptimal image 
quality due to lower sensitivity and speed than novel technologies of SD-OCT and 
swept-source OCT (SS-OCT). In recent years, to overcome suboptimal imaging 
during surgeries, researchers have discovered the microscope-integrated OCT 
devices (MIOCTs). So far, a short overview about the evolution of iOCT devices was 
introduced. The following section will discuss various iOCT systems and devices 
and their technologies.
2.1 Intraoperative OCT systems and devices
iOCT devices can be classified into two main categories: portable OCT during 
surgical pauses and microscope-integrated OCT (MIOCT). Subsequently, portable 
OCTs have three subgroups: handheld, external-mounted, and microscope-
mounted. On the other hand, MIOCTs have two subgroups: live two-dimensional 
(2D) OCT imaging and live four-dimensional (4D) OCT imaging (Tables 1 and 2).
2.1.1 Portable OCT devices
Portable OCT devices were the beginning step for iOCT. There are two basic por-
table systems in the literature: the Bioptigen EnVisu (Bioptigen, Research Triangle 
Park, NC/Leica, Wetzlar, Germany) and the Optovue iVue (Optovue, Fremont, CA, 
USA) [6, 11–13]. These devices can be used with the systems, including handheld, 
external-mounted, and microscope-mounted for image acquisition.
Handheld imaging was the first examples of the portable OCTs [11, 14]. This 
system has a compact handheld imaging probe connected over flexible optical fiber to 
a portable device. In spite of restrictions on image reproducibility and optimal aiming 
with the device, handheld imaging can present a good image quality. Moreover, unlike 
clinic tabletop OCT devices, handheld OCT has no requirement upright and coopera-
tive patient situation. Nevertheless, the need to protect the sterile surgical field and 
the occurrence of motion artifacts due to instability are examples of several handicaps 
of handheld OCT. More importantly, the main disadvantage of handheld OCT is that 
it is limited to surgical pauses because of the need to remove the microscope from the 
patient during imaging. Unfortunately, it is impossible to obtain images of the struc-
tural changes that ensued from live tissue-instrument interactions during surgery.
System OCT 
technology
Speed, 
resolution, 
wavelength
Primary 
visualization 
modes
Modes of 
operation
Commercial 
status
Optovue 
iVue
Spectral 
domain
26k, 5 lm, 
840 nm
B-scans, volumes, 
en face on 
external monitor
Mounted onto 
stabilizing arm
FDA 
approved
Bioptigen 
Envisu
Spectral 
domain
17–32k†, 
3–5† lm, 
870 nm
B-scans, en face 
on external 
monitor
Handheld, 
mounted onto 
microscope
FDA 
approved
aSpeed is listed in terms of A-scans/second; resolution refers to axial resolution; wavelength refers to the central 
wavelength of the source.
†Not specified in publications. Range provided by manufacturer.
Table 1. 
System specifications and features of commercial HHOCT systems used in human retinal surgery to date.a With 
the permission of Carrasco-Zevallos OM et al. under the license of CC licensing [23].
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Mounting systems for the portable OCT systems were developed to address most 
of the handheld imaging. These external mounts contribute more stability, yet these 
systems require a supplementary footprint and place in the operating room [4, 6]. 
The microscope holders allow the surgeon to attach the portable probe directly 
to the microscope body, thus providing more stability than handheld imaging. 
Microscope foot pedal controls make it possible to control the probe position with 
X-Y-Z foot pedals. This foot pedal control makes easier imaging with improved 
image repeatability [4].
Unfortunately, the main disadvantage of portable OCTs is that it is limited to 
surgical pauses because of the need to remove the microscope from the patient 
during imaging. In other words, it is impossible to obtain images of the structural 
changes that ensued from live tissue-instrument interactions during surgery.
2.1.2 Microscope-integrated OCT devices
A step-by-step initiative in the iOCT has been the integration of OCT into 
microscope optics called MIOCT. Leica (Leica, Wetzlar, Germany) and Zeiss (Carl 
Zeiss Meditec, Oberkochen, Germany) were the first examples of these systems. In 
the Zeiss adaptation, a modified Cirrus (Carl Zeiss Meditec) and a modified Visante 
(Carl Zeiss Meditec) OCT system integrated into Zeiss microscope optical path 
for the posterior and anterior segment imaging, respectively, were used [3, 15, 16]. 
These two systems allow surgeons for real-time imaging by visualizing the instru-
ment-tissue interaction. On the other hand, these two systems bring with it new 
software requirements, the need for heads-up image acquisition, and the compatibil-
ity of OCT with the surgical instrument used during imaging. Additionally, surgical 
maneuvers during the surgery also require Z-axis stabilization and automated track-
ing system to improve image quality. After the investigation of first MIOCT systems, 
three commercial systems were identified. Zeiss Rescan 700 was defined as the first 
FDA-approved MIOCT system. This system is integrated into the Zeiss Lumera 700 
System OCT 
technology
Speed, 
resolution, 
wavelength
Primary 
visualization 
modes
OCT acquisition 
and features
Commercial 
status
Haag-
Streit 
surgical 
iOCT
Spectral 
domain
10k, 10 lm, 
840 nm
Live B-scans 
on binocular, 
monoscopic 
HUD
OCT operator 
control, surgeon 
control of OCT 
display via foot 
pedal, optical 
zoom
FDA approved
Zeiss 
Rescan 
700
Spectral 
domain
27k, 5.5 lm, 
840 nm
Live 
B-scans on 
monocular, 
monoscopic 
HUD
OCT operator 
control with 
tracking, surgeon 
control of OCT 
scan location via 
foot pedal
FDA approved
Bioptigen 
EnFocus
Spectral 
domain
32k, 4 lm, 
860 nm
Live B-scans, 
static en face 
on external 
monitor
OCT operator 
control, surgeon 
control via foot 
pedal
FDA approved
aSpeed is listed in terms of A-scans/second; resolution refers to axial resolution; wavelength refers to the central 
wavelength of the source.
Table 2. 
System specifications and features of all commercial MIOCT systems used in human retinal surgery to date.a 
With the permission of Carrasco-Zevallos OM et al. under the license of CC licensing [23].
Novel Diagnostic Methods in Ophthalmology
4
microscope platform. Zeiss Rescan 700 was also integrated into the microscope foot 
pedal system to provide surgeon targeting, orientation control. More importantly, 
Zeiss Rescan 700 has the first MIOCT having Z-tracking system [17, 18]. The second 
FDA-approved MIOCT system was the Haag-Streit MIOCT system (Haag-Streit, 
Koeniz, Switzerland). This system consists of a side port using OPMedT (OPMedT, 
Lübeck, Germany) OCT system. This system has not only a microscope-mounted 
viewing but also a heads-up screen too [19]. Unlike Zeiss Rescan, the Haag-Streit 
Surgical iOCT has no control system with Z-tracking; differently, this system has an 
optical zoom. The third commercially available and FDA-approved MIOCT system 
was Bioptigen EnFocus iOCT system. This system can be adapted to both Leica and 
Zeiss microscopes. The system has a 4-μm resolution and a different static en face on 
external monitor as a visualization mode. Dissimilarly, Bioptigen EnFocus system 
has an essential long-fiber that provides more flexibility to insert the OCT device 
and its computer inside the operating room (Figure 1) [20].
With regard to limitations of the MIOCT devices, while a volumetric data could 
be obtained, acquisition of the volume is slow, and volume analysis as well as visual-
ization has necessitated comprehensive postprocessing. Another important limita-
tion of MIOCT devices is an inefficient display of continuous instrument movement 
due to intraoperative real-time visualization limited by B-scans. In other words, 
intraocular instruments used during live surgery generally give rise to shadows on 
the underlying tissue in B-scan mode. This issue requires alignment of the surgical 
maneuvers with the B-scan to eliminate instrumental ghosting during surgery. Ehlers 
et al. [21] described and characterized this shadowing effect with ex vivo porcine eye 
surgeries. Regarding surgical instrument shading, some authors have suggested the 
idea of an automated instrument tracking system using a stereo camera pair [22].
Figure 1. 
Live 2D MIOCT imaging of human retinal surgery with the commercially available Rescan 700 and a 
Cirrus HD-OCT system adapted to an operating microscope. (A) Frame captured with the camera that 
records the surgeon’s view through the operating microscope. The orthogonal arrows correspond to the B-scan 
locations. (B) Horizontal (B1) and vertical (B2) B-scans acquired with the Rescan 700 during inner limiting 
membrane (ILM) peeling. The membrane edge (white arrowheads) is clearly visible in the B-scans along with 
“shadowing” (yellow arrowheads) from the intraocular forceps. With the permission of Carrasco-Zevallos OM 
et al. under the license of CC licensing [23].
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All real-time MIOCTs described above were limited to B-scan due to involve-
ment of SD-OCT system having slower A-scan rate. Carrasco-Zevallos et al. 
[23] were the first authors who described the volumetric iOCT imaging of live 
model eye surgery. They presented a custom ultrafast SS-OCT system operating 
at 100 kHz of A-scan rate. This speed was three to five times faster than previ-
ous MIOCT devices. A software called a special graphics-processing unit was 
simultaneously used to get, process, and render volumes. Later, the same authors 
developed a custom microscope-integrated heads-up display (HUD) unit for ste-
reoscopic imaging of MIOCT volumes [24, 25]. SS-MIOCT and stereoscopic HUD 
together were called as 4D MIOCT. In 2015, 4D MIOCT was first demonstrated by 
Carrasco-Zevallos et al. [23] for imaging of human retinal surgery. The volumetric 
frame rate varied 3.3–10 volumes per second during the surgery. Through a special 
mode “stream saving,” OCT volumes were saved, and thus continuous volumetric 
recording could be acquired in the surgery. Visualization of the stereoscopic vol-
umes by the HUD was enabled, and the surgeon could control the volume render-
ing via a foot pedal joystick.
Although 4D MIOCT devices have faster scan rate than 2D MIOCT due to faster 
A-scan rate, it requires faster A-scan rate as well as human flicker fusion rate (16 Hz) 
to attain optimal lateral resolution. In addition to that, instrumental shading effect is 
still one of the major limitations in 4D MIOCT as well in 2D MIOCT devices.
2.2 Clinical applications of intraoperative OCT
In this part of the chapter, we will provide information on the clinical use of 
iOCT. In terms of both anterior and posterior segments, there are numerous of clini-
cal studies related to feasibility and real-time assessment of the surgical feedback 
during the anterior and posterior surgeries [4–6, 11, 13, 14, 16–18, 20]. The two most 
important prospective clinical studies are the PIONNER study and the DISCOVER 
study [4, 20]. In these studies, the portable microscope-mounted iOCT in the 
PIONNER study (n = 531) and the microscope-integrated iOCT in the DISCOVER 
study (n = 227) were evaluated. There are not only large-scale prospective but also 
numerous smaller clinical studies in the literature. In the section that follows, feasi-
bility and efficacy of iOCT for the anterior segment applications will be argued.
2.2.1 Anterior segment
Intraoperative OCT has been used for various anterior segment surgeries involv-
ing penetrating and lamellar keratoplasty, cataract surgeries, and excisional biopsy 
procedures [4, 15, 16, 19, 22].
iOCT has been used for full-thickness and lamellar keratoplasty surgeries for 
decision-making. Particularly, iOCT can be very useful to evaluate in cases with 
extensive synechiae or iridocorneal scars. It may help to protect iris tissue from 
traumas during initial trephination [26]. Furthermore, the graft-host position can 
be estimated during surgery; thereby, it can help to construct proper graft-host rela-
tionship. In anterior lamellar keratoplasty, the presence of residual corneal opaci-
ties following microkeratome-assisted removal of anterior stromal layers can be 
detected, and their extensions may be easily confirmed by iOCT. Again, the thick-
ness of residual stromal bed can be assessed, thus increasing the safety of operation 
[27]. As is known, it is very important to maintain an intact descemet membrane 
(DM) during deep anterior lamellar keratoplasty (DALK), and large bubble tech-
nique is widely used for this purpose. The iOCT helps to confirm the presence of 
large bubbles, detect subclinical large bubbles, and conduct additional dissections. 
In addition to these, the presence of any interface fluid can be determined with 
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the help of the iOCT, thus helping to determine the extra maneuvers that need to 
be done to ensure proper position of tissues to the end of the surgery. However, 
the instrumental shadowing effect may hinder the visualization of the underlying 
structures, thereby limiting the effective use of iOCT during intrastromal insertion 
of the needle. Therefore, surgical pause is necessary to evaluate the underlying 
tissues [17, 28, 29]. iOCT is a helpful intraoperative imaging method not only in 
full-thickness and lamellar but also in endothelial keratoplasty applications, e.g., 
descemet stripping automated endothelial keratoplasty (DSAEK) and descemet 
membrane endothelial keratoplasty (DMEK). Especially, in double-pass technique 
in DSAEK, the residual donor thickness following the first microkeratome passing 
can be easily determined with guiding iOCT to select of ideal blade size for the 
next microkeratome passing. This will minimize the chance of perforation of donor 
tissue by obtaining very thin donor lenticules [30]. Additionally, iOCT provides 
an advantage to identify and remove the descemet membrane in case of extreme 
edematous corneas. Furthermore, iOCT allows a continuous monitoring during the 
graft insertion and unfolding process. In DMEK, iOCT is a very convenient tool to 
provide faster graft orientation and position, especially in cases with edematous 
cornea [31]. In the DISCOVER study, it was reported that the surgeons required 
additional surgical maneuvers in 41% of the cases having DSAEK [18]. Similarly, 
in the PIONNER study, results showed that 19% of the cases in which surgeons 
believed the graft was completely apposed had still persistent fluid detected in 
the iOCT; hence, it would require more maneuvers and vice versa; in 47% of cases 
where the surgeon believed the graft to be partially apposed, there was complete 
apposition in iOCT imaging [4]. These two studies have also revealed that iOCT aids 
changes in dissection depth in 38–56% of cases [4, 20]. Briefly, it can be concluded 
that iOCT in keratoplasty procedures can minimize unnecessary manipulations and 
surgical time.
Recently, iOCT has been used in various stages of a cataract surgery. The wound 
structure, status of posterior capsule, and position of intraocular lens (IOL) can 
be easily assessed via iOCT during a cataract surgery [32]. In a case report, it was 
reported that MIOCT was a very feasible tool to evaluate the wound architecture, 
integrity of the posterior capsule, IOL position, and efficacy of stromal hydration. 
The authors suggested that iOCT could be helpful in real-time early detection of 
various complications of cataract surgery, thus allowing the surgeon to manage the 
complication immediately [33].
More recently, in taking biopsy and excisional procedures, such as retrocorneal 
fibrosis and pterygium excision, and evaluating intraoperative changes in corneal 
structure during excimer laser phototherapeutic keratectomy, feasibility of iOCT 
was assessed, and the results were promising [34, 35].
2.2.2 Posterior segment
Similar to the use of iOCT for anterior segment surgery, iOCT has a wide range 
of potentials for posterior segment surgery. Numerous vitreoretinal pathologies 
were described with iOCT, such as retinopathy of premature (ROP), prolifera-
tive diabetic retinopathy, macular hole, epiretinal membrane (ERM), retinal 
detachment, and myopic foveoschisis [4, 5, 20, 36–39]. The iOCT has provided 
new insights into the underlying pathophysiology for some of these conditions. 
PIONEER and DISCOVER studies provided valuable information about iOCT for 
posterior segment surgeons [4, 20]. We will discuss the results of these studies at 
the end of this section.
Chavala et al. [11] reported that they identified preretinal structures and reti-
noschisis with iOCT in case of ROP. They suggested that these new findings might 
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markedly affect the surgeons to make a decision resulting in various alterations 
during the operation. It is thought that iOCT may allow the surgeons to assess the 
extents of both horizontal and anteroposterior tractional structures in ROP cases; 
thus, the surgeons could carefully dissect or peel while sparing the other retinal 
structures. Additionally, iOCT is very useful detecting the flat neovascular fronds 
in ROP cases as well as other vascular retinopathies; thereby, this could prevent 
iatrogenic hemorrhages by determining the extent and location of the neovascular 
fronds during the surgery.
The iOCT helps the surgeon to determine the firmness of vitreomacular trac-
tions; therefore, in case of foveal cyst, de-roofing risk would diminish, and inad-
vertent macular hole could be eliminated. Similarly, during an ERM and internal 
limiting membrane (ILM) peeling, the iOCT decreases the risk of inadvertent 
grasping of the retina while completing ERM/ILM peeling (Figure 2).  
In a recent study, it was reported that a membrane peeling with the guidance 
of iOCT was enabled without the use of adjuvant dyes to identify of membrane 
edges [36]. Especially in a macular hole surgery, this advantage of iOCT allows 
visualization of the alterations in the macular hole architecture as well as in the 
outer retina [37, 40]. In addition, during a macular hole surgery, the surgeon may 
worry about inadvertent touching or tearing on nerve fiber layer. In such situa-
tion, the iOCT with real-time feedback can prevent inadvertent damage on nerve 
fiber layer.
One of the retinopathies in which the iOCT is used is myopic foveoschisis. As 
known, there are multiple layers of schisis in this retinopathy, and this involves 
vital dye staining to make certain that the whole cortical vitreous has been 
removed. However, the cases with myopic foveoschisis have a longer axial length, 
thus giving rise to poor dying. The iOCT can allow not only to better evaluate the 
ILM but also to prevent iatrogenic breaks by improving visualization in a myopic 
retina.
iOCT enables to provide more information in retinal detachment cases. In recent 
various studies, the iOCT revealed the presence of subclinical persistent subretinal 
fluid under perfluorocarbon tamponade in most of the cases undergoing retinal 
Figure 2. 
B-scan (C1) and volume (C2) acquired intraoperatively before epiretinal membrane (ERM) peeling with 
the reconfigured Cirrus HD-OCT system. B-scan (D1) and volume (D2) acquired after ERM peeling. The 
volumes required intensive postprocessing to render and were visualized postoperatively. The prepeeling volumes 
depict ERM and puckering of the retina, while the post-peeling volumes show a small residual part of ERM 
(Figure 1). With the permission of Carrasco-Zevallos OM et al. under the license of CC licensing [23].
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detachment operation [4, 5, 20]. Furthermore, iOCT can help to detect proliferative 
vitreoretinopathy changes and border architecture of retinal tears.
In proliferative diabetic retinopathy, iOCT provides an enhanced imaging during 
delamination of membranes. For this reason, the iOCT facilitates the identification 
of the surgical plane, which permits membrane peeling in a safe manner. In addition 
to that, in the cases of dense vitreous hemorrhage, iOCT can help to assess intra-
operatively the underlying macular pathology, such as intraretinal fluid, macular 
edema, or presence of a membrane, which may impact the surgeon in changing 
operation plan [38, 39].
Recently, in the 3-year outcome reports of the DISCOVER study, the use of iOCT 
for image-guided retinal biopsy and placement of Argus II implant was reported. 
It was demonstrated that iOCT facilitates insertion of the biopsy site and enabled 
confirming placement of the implant in optimal location [41, 42]. More recently, a 
few studies reported the use of iOCT verifying subretinal location of gene therapy 
and stem cells during the operation [43, 44].
Finally, the outcomes in posterior segment surgery in the PIONNER and 
DISCOVER studies showed that iOCT identified residual membranes in 13–22% of 
the cases whom the surgeon believed that membrane peeling was completed; con-
versely, in 15–40% of the cases, the surgeon still thought the presence of residual 
membrane, yet iOCT indicated that complete removal of the membrane had been 
performed [4, 20]. Additionally, iOCT provided addition of useful data concerning 
surgical anatomic features in 59.4% of the cases, and the information obtaining 
with iOCT impacted the surgery in 29.2% of the cases [20].
3. Conclusion
As known, in a very short time, conventional tabletop OCT has acquired its 
place in practice; subsequently, real-time intraoperative feedback with the iOCT 
appears to be a revolution in the OCT technology. Up to now, overall study reports 
related to iOCT, especially the PIONNER and DISCOVER study, have enhanced our 
understanding of iOCT technology and its unique advantages in surgical efficiency. 
iOCT may lead to refine and replace conventional surgical procedures with novel 
procedures, so that, with this technology, improved individual surgical manage-
ment and patient care can be achieved. However, this technology has still a few 
limitations. The overall outcomes related to feasibility of iOCT need to be validated 
with additional prospective randomized trials.
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